OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP)

 

To Effeciently Deliver Vaccines Directly to the Skin, Enhancing Immunogenicity

 

Read the full media release below.

Learn more
 
Media ReleaseCarolyn MillerMarch 17, 2020Vaxxas, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

Bill Gates backs Aussie patch-up for next pandemic

AFRCarolyn MillerMarch 18, 2020Vaxxas, Paul Kelly
Next

Why 20-year-old Aussie tech firm is taking on start-up style funding

AFRCarolyn MillerMarch 16, 2020Phocas

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379


Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd